We are building an advisory board of exceptional leaders to guide us in areas like healthcare product development, commercialization, and market strategy. Current advisors include experienced thought leaders such as Jennifer Berman, Shivang Joishi and Peter McAllister that play a vital role in shaping the direction and strategy of Brightmind.AI.

Company achievements: 

• Game-changing efficacy: Clinical trials showing 3-4x better results compared to standard of care

• Pivotal progress: Ongoing clinical trial with 88 patients at a leading research institution in Europe 

• Notable Achievements: €3.3M raised, including €2.4M non-dilutive funding from FFG and AWS  

• Industry Recognition: Selected among the Top 30 EIT Health Catapult Program startups. 

• Key Partnerships: Selected for direct investment by The University of Oxford, advancing our commercialization and scientific capabilities through institutional backing. 

• Proprietary Technology & IP: Developed 1st and 2nd generation devices in-house, successfully used in clinical trials, with a patent filed for our proprietary brain stimulation technology 

Role of Advisors/Investors:

•  Provide strategic input and guidance
• Facilitate key introductions
• Collaborate with our management team

Benefits to Advisors/Investors:

• Opportunity to invest $25k+ and receive equity compensation through stock options 
• Make a tangible impact on preventing migraine attacks and further neurological disorders
• Collaboration with other thought leaders and strategic partners 
• The opportunity to shape our US market entry strategy and build relationships with key healthcare stakeholders